ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 on Clinical & PROs in a Phase III, Randomized, Open-Label Study Evaluating Axicabtagene Ciloleucel vs. SoC Therapy in Elderly Pts With R/R LBCL
By
ASCO 2022 Conference Coverage
FEATURING
Jason Westin
By
ASCO 2022 Conference Coverage
FEATURING
Jason Westin
Login to view comments.
Click here to Login
Lymphoma